Most Accessed Articles


Use of human Dihydroorotate Dehydrogenase (hDHODH) Inhibitors in Autoimmune Diseases and New Perspectives in Cancer Therapy

, 2018; 13(1): 86-105.

Marco L. Lolli, Stefano Sainas, Agnese C. Pippione, Marta Giorgis, Donatella Boschi and Franco Dosio*


DOI: 10.2174/1574892812666171108124218



PARP Inhibitors in Epithelial Ovarian Cancer

, 2018; 13(2): 145-158.

Kristin N. Taylor and Ramez N. Eskander*


DOI: 10.2174/1574892813666171204094822



Targeting Mevalonate Pathway in Cancer Treatment: Repurposing of Statins

, 2018; 13(2): 184-200.

Federica Iannelli, Rita Lombardi, Maria R. Milone, Biagio Pucci, Simona De Rienzo, Alfredo Budillon* and Francesca Bruzzese*


DOI: 10.2174/1574892812666171129141211



Adenosine Receptor Ligands on Cancer Therapy: A Review of Patent Literature

, 2018; 13(1): 40-69.

Joana B. Sousa, Paula Fresco, Carmen Diniz* and Jorge Goncalves


DOI: 10.2174/1574892812666171108115959



Advances in Chalcones with Anticancer Activities

, 2015; 10(1): 97-115.

Chandrabose Karthikeyan, Narayana S.H. Narayana Moorthy, Sakthivel Ramasamy, Uma Vanam, Elangovan Manivannan, Devarajan Karunagaran and Piyush Trivedi


DOI: 10.2174/1574892809666140819153902



Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science